Strategic Advisory Board

Meet our strategic advisors.

InfoBionic’s Strategic Advisory Board consists of respected leaders in the field of cardiology. They provide expert perspectives and guidance to ensure our MoMe® ARC Platform system is optimized to meet the needs of its users.

Jeffrey F. Feiner, M.D. F.A.C.C.
Managing Partner, South Orange County Cardiology Group

Dr. Jeffrey Feiner is a general and invasive cardiologist who has been in practice for since 1982. Dr. Feiner founded and is now managing a 10 physician full services cardiology group while caring for his own patients. He is in charge of HR, contracting, IT, maintenance and vendor relationships, as well as maintaining electronic medical records system for the group. He is board certified in the American College of Cardiology and American College of Internal Medicine.

Matthew Goldstein, MD, FACC, HFRS

Matthew B. Hillis, MD, FACC, FHRS
Cardiac Electrophysiologist

Dr. Hillis is a cardiac electrophysiologist with the Lankenau Heart Group at Bryn Mawr Hospital. His practice focuses on clinical cardiac electrophysiology and cardiac device implantation and management. He graduated from Harvard University with a degree in Biology, cum laude and received his medical degree from Columbia University P&S where he was elected to the Alpha Omega Alpha honor society. He completed his internal medicine residency at the Hospital of the University of Pennsylvania and fellowships in cardiology and cardiac electrophysiology at Thomas Jefferson University.

Evan May, MD, FACC
Partner, El Paso Cardiology Associates, P.A.

Philip Nimoityn, MD, FACC
Clinical Assistant Professor of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University

Philip Nimoityn, MD, FACC, is a clinical cardiologist at Cardiology Consultants of Philadelphia at Jefferson. He has a Bachelor of Science degree in Biology with Distinction from the University of the Sciences and a Doctor of Medicine degree from Sidney Kimmel Medical College at Thomas Jefferson University. His internship was at Drexel University College of Medicine/Hahnemann University Hospital, and his residency in internal medicine and fellowship in cardiovascular disease were at Thomas Jefferson University Hospital. He is a diplomate of the American Board of Internal Medicine and Subspecialty Board of Cardiovascular Disease and is a Fellow of the American College of Cardiology. He is also a member of the National Lipid Association. Dr. Nimoityn is a Clinical Assistant Professor of Medicine at Sidney Kimmel Medical College at Thomas Jefferson University and an Attending Physician at Thomas Jefferson University Hospital, where he has held numerous leadership positions including President of the Medical Staff, chair of several committees of the medical staff, member of the hospital Board of Trustees, and has been a member of the Executive Committee of the Medical Staff for 18 years. He has published in the fields of genetic disease, perioperative cardiovascular medicine, and lipid disorders. His interest in ambulatory cardiac monitoring began as a child when he assisted his father load reel-to-reel magnetic tapes into the first commercially available Holter monitor recorders soon after they were introduced. He has been actively involved with the clinical use of all generations of ambulatory cardiac monitoring and has participated in clinical trial evaluation of the technology.

Jeremy Ruskin, MD – Chairman
Founder and Director, Cardiac Arrhythmia Service, Massachusetts General Hospital

Dr. Ruskin is a world-renowned cardiologist and electrophysiologist. He is Founder and Director of the Cardiac Arrhythmia Service at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. Dr. Ruskin received his undergraduate degree from Tufts University and his medical degree from Harvard Medical School. He completed his residency in Internal Medicine at Beth Israel Hospital in Boston and his fellowship in Cardiovascular Disease at the Massachusetts General Hospital. He received his training in clinical and experimental cardiac electrophysiology at the USPHS Hospital in Staten Island, New York under the mentorship of Dr. Anthony Damato.

Dr. Ruskin has trained more than 110 fellows in the subspecialty of cardiac arrhythmias over the past 38 years, many of whom are in leadership positions at academic centers throughout the world. In addition, Dr Ruskin is a much sought after speaker at medical conferences and has authored more than 450 original scientific publications, chapters, reviews, and monographs. Dr. Ruskin’s major research interests include: the mechanisms and management of atrial fibrillation; new antiarrhythmic drugs and innovative non-pharmacologic approaches to the treatment of atrial fibrillation; the mechanisms and prevention of ventricular arrhythmias and sudden cardiac death; the role of arrhythmia control devices in the prevention of sudden cardiac death; the proarrhythmic effects of cardiac and non-cardiac drugs and cardiac safety issues in new drug and device development. In 1995, Dr. Ruskin founded the Annual International Atrial Fibrillation Symposium which he has directed since its inception and is the largest and longest running free-standing academic meeting on atrial fibrillation worldwide. Dr. Ruskin also maintains an active regional, national and international referral practice in the field of cardiac arrhythmias and electrophysiology and is recognized annually in Best Doctors in Boston and Best Doctors in America. He is the recipient of the 1997 Michel Mirowski Award for Excellence in Clinical Cardiology and Electrophysiology and the 2002 Heart Rhythm Society Pioneer in Pacing and Electrophysiology Award.